Cited by

• The role of rTMS for patients with severe PTSD and depression.

  Fryml LD, Sahlem G, Fox J, Short EB. Fryml LD, et al. Evid Based Ment Health. 2018 Feb;21(1):39-40. doi: 10.1136/eb-2017-102819. Epub 2018 Jan 5. Evid Based Ment Health. 2018. PMID: 29305359 Free PMC article. No abstract available.
• Synchronised transcranial magnetic stimulation for substance use-disordered Veterans: protocol for the pilot sham-controlled acceptability trial.

  Jampel J, Quinn MJ, Catalano JL, Benca-Bachman CB, Brick L, Philip NS, Swift RM, McGeary JE. Jampel J, et al. BMJ Open. 2023 Jan 30;13(1):e066175. doi: 10.1136/bmjopen-2022-066175. BMJ Open. 2023. PMID: 36717148 Free PMC article. Clinical Trial.
• TMS-evoked potential in the dorsolateral prefrontal cortex to assess the severity of depression disease: a TMS-EEG study.

  Li X, Chen M, Liu Q, Zheng C, Yu C, Hou G, Chen Z, Chen Y, Chen Y, Zhu G, Zhou D, Xu W. Li X, et al. Front Pharmacol. 2023 Jun 5;14:1207020. doi: 10.3389/fphar.2023.1207020. eCollection 2023. Front Pharmacol. 2023. PMID: 37342593 Free PMC article.
• Triple-site rTMS for the treatment of chronic tinnitus: a randomized controlled trial.

  Lehner A, Schecklmann M, Greenlee MW, Rupprecht R, Langguth B. Lehner A, et al. Sci Rep. 2016 Mar 1;6:22302. doi: 10.1038/srep22302. Sci Rep. 2016. PMID: 26927363 Free PMC article. Clinical Trial.
• Repetitive transcranial magnetic stimulation (rTMS) augmentation of selective serotonin reuptake inhibitors (SSRIs) for SSRI-resistant obsessive-compulsive disorder (OCD): a meta-analysis of randomized controlled trials.

  Ma ZR, Shi LJ. Ma ZR, et al. Int J Clin Exp Med. 2014 Dec 15;7(12):4897-905. eCollection 2014. Int J Clin Exp Med. 2014. PMID: 25663986 Free PMC article.